C. Guzmán

2.0k total citations
31 papers, 1.0k citations indexed

About

C. Guzmán is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Health, Toxicology and Mutagenesis. According to data from OpenAlex, C. Guzmán has authored 31 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cancer Research, 6 papers in Pulmonary and Respiratory Medicine and 6 papers in Health, Toxicology and Mutagenesis. Recurrent topics in C. Guzmán's work include Synthesis and Biological Activity (7 papers), Climate Change and Health Impacts (5 papers) and Beetle Biology and Toxicology Studies (3 papers). C. Guzmán is often cited by papers focused on Synthesis and Biological Activity (7 papers), Climate Change and Health Impacts (5 papers) and Beetle Biology and Toxicology Studies (3 papers). C. Guzmán collaborates with scholars based in United States, Spain and Netherlands. C. Guzmán's co-authors include José Jimeno, Rocio García‐Carbonero, Luis López Lázaro, George D. Demetri, Robert G. Maki, Rámón Colomer, David C. Harmon, Geraldine Goss, Michael V. Seiden and Thomas A. Puchalski and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

C. Guzmán

29 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Guzmán United States 14 555 418 252 223 160 31 1.0k
Piotr J. Wysocki Poland 22 381 0.7× 821 2.0× 192 0.8× 386 1.7× 59 0.4× 136 1.4k
Ik Joo Chung South Korea 19 278 0.5× 352 0.8× 232 0.9× 416 1.9× 34 0.2× 57 1.4k
A. Bowman United Kingdom 16 182 0.3× 354 0.8× 105 0.4× 171 0.8× 46 0.3× 35 739
R. M. Goldberg United States 16 209 0.4× 587 1.4× 132 0.5× 410 1.8× 22 0.1× 29 1.1k
Eva Brandén Sweden 17 488 0.9× 432 1.0× 204 0.8× 304 1.4× 33 0.2× 47 1.0k
Joshua A. Roth United States 20 316 0.6× 564 1.3× 230 0.9× 311 1.4× 31 0.2× 71 1.4k
Jurandyr Moreira de Andrade Brazil 21 158 0.3× 690 1.7× 290 1.2× 317 1.4× 40 0.3× 114 1.5k
Bart C. Kuenen Netherlands 17 264 0.5× 519 1.2× 176 0.7× 511 2.3× 115 0.7× 31 1.2k
Alessandra Ravaioli Italy 19 533 1.0× 913 2.2× 209 0.8× 210 0.9× 38 0.2× 107 1.3k
Iuliana Shapira United States 20 247 0.4× 787 1.9× 442 1.8× 244 1.1× 179 1.1× 53 1.6k

Countries citing papers authored by C. Guzmán

Since Specialization
Citations

This map shows the geographic impact of C. Guzmán's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Guzmán with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Guzmán more than expected).

Fields of papers citing papers by C. Guzmán

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Guzmán. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Guzmán. The network helps show where C. Guzmán may publish in the future.

Co-authorship network of co-authors of C. Guzmán

This figure shows the co-authorship network connecting the top 25 collaborators of C. Guzmán. A scholar is included among the top collaborators of C. Guzmán based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Guzmán. C. Guzmán is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guzmán, C., Nicole Redvers, John S. Ji, et al.. (2025). Planetary Health: Focusing on the Intersection of Human Health and the Earth System. Annual Review of Environment and Resources. 50(1). 303–337.
2.
Jacobsen, Kathryn H., et al.. (2024). Planetary health education in the United States: four curricular models, one goal. International Journal of Environmental Health Research. 34(10). 3672–3681.
3.
Friel, Sharon, et al.. (2024). Governance for planetary health equity—the Planetary Health Equity Hothouse project. The Lancet Planetary Health. 8. S15–S15. 1 indexed citations
4.
Guzmán, C.. (2024). Global health in the age of AI: Safeguarding humanity through collaboration and action. SHILAP Revista de lepidopterología. 4(1). e0002778–e0002778. 3 indexed citations
5.
Howard, Courtney, Geneviève Moineau, Julien Poitras, et al.. (2023). Seeding a planetary health education revolution: institutional sign-on challenge. The Lancet. 402(10418). 2173–2176. 6 indexed citations
6.
Redvers, Nicole, C. Guzmán, & Margot W. Parkes. (2023). Towards an educational praxis for planetary health: a call for transformative, inclusive, and integrative approaches for learning and relearning in the Anthropocene. The Lancet Planetary Health. 7(1). e77–e85. 26 indexed citations
7.
Castañeda, Rafael Ruiz de, C. Guzmán, Catherine Machalaba, et al.. (2023). One Health and planetary health research: leveraging differences to grow together. The Lancet Planetary Health. 7(2). e109–e111. 43 indexed citations
8.
Guzmán, C.. (2022). Complexity in Global Health– Bridging Theory and Practice. Annals of Global Health. 88(1). 49–49. 12 indexed citations
9.
10.
Guzmán, C., et al.. (2021). Willingness to Get a COVID-19 Vaccine and Its Potential Predictors in Costa Rica: A Cross-Sectional Study. Cureus. 13(10). e18798–e18798. 3 indexed citations
11.
Kalbarczyk, Anna, et al.. (2020). Practical and Ethical Solutions for Remote Applied Learning Experiences in Global Health. Annals of Global Health. 86(1). 103–103. 16 indexed citations
12.
Ruíz‐Borrego, Manuel, J. Salvador, F. Carabantes, et al.. (2009). Different Treatment Benefit for Luminal A and Luminal B Advanced Breast Cancinomas Receiving Aromatase Inhibitors.. Cancer Research. 69(24_Supplement). 5141–5141. 2 indexed citations
13.
Castellano, Daniel, Xavier García del Muro, José Luis Perez‐Gracia, et al.. (2009). Patient-reported outcomes in a phase III, randomized study of sunitinib versus interferon-α as first-line systemic therapy for patients with metastatic renal cell carcinoma in a European population. Annals of Oncology. 20(11). 1803–1812. 23 indexed citations
14.
Fernández, Sònia, et al.. (2007). Pharmacoeconomic Impact of the Sunitinib Adverse Events (AEs) Prophylaxis Treatment in Spain. Drug Safety. 30(10). 919–990. 1 indexed citations
15.
García‐Carbonero, Rocio, Judith Manola, Michael V. Seiden, et al.. (2004). Phase II and Pharmacokinetic Study of Ecteinascidin 743 in Patients With Progressive Sarcomas of Soft Tissues Refractory to Chemotherapy. Journal of Clinical Oncology. 22(8). 1480–1490. 250 indexed citations
16.
Twelves, Chris, Klaas Hoekman, A. Bowman, et al.. (2003). Phase I and pharmacokinetic study of Yondelis™ (Ecteinascidin-743; ET-743) administered as an infusion over 1 h or 3 h every 21 days in patients with solid tumours. European Journal of Cancer. 39(13). 1842–1851. 75 indexed citations
17.
Albella, Beatriz, Glynn Faircloth, Luis López Lázaro, et al.. (2002). In vitro toxicity of ET-743 and aplidine, two marine-derived antineoplastics, on human bone marrow haematopoietic progenitors. European Journal of Cancer. 38(10). 1395–1404. 27 indexed citations
18.
Kesteren, Charlotte van, Esteban Cvitkovic, A. Taamma, et al.. (2001). A comparison of limited sampling strategies for prediction of Ecteinascidin 743 clearance when administered as a 24-h infusion. Cancer Chemotherapy and Pharmacology. 48(6). 459–466. 11 indexed citations
19.
Colomer, Rámón, Jorge Aparicio, S Montero, et al.. (1997). Low levels of basic fibroblast growth factor (bFGF) are associated with a poor prognosis in human breast carcinoma. British Journal of Cancer. 76(9). 1215–1220. 52 indexed citations
20.
Guzmán, C., et al.. (1996). [Resectable stomach cancer: analysis of 134 consecutive cases].. PubMed. 15(3). 265–72. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Piotr J. Wysocki Breakdown of academic impact, for papers by Ik Joo Chung Breakdown of academic impact, for papers by A. Bowman Breakdown of academic impact, for papers by R. M. Goldberg Breakdown of academic impact, for papers by Eva Brandén Breakdown of academic impact, for papers by Joshua A. Roth Breakdown of academic impact, for papers by Jurandyr Moreira de Andrade Breakdown of academic impact, for papers by Bart C. Kuenen Breakdown of academic impact, for papers by Alessandra Ravaioli Breakdown of academic impact, for papers by Iuliana Shapira
Rankless by CCL
2026